article thumbnail

Henrietta Lacks’ immortal cells put biopharma profits under a microscope

PharmaVoice

The HeLa cell line’s contributions to medical science were obtained without permission, and now biotechs profiting from its use are answering for it.

article thumbnail

Modern KOL Connections: Engaging with Thought Leaders in the Age of AI

MedCity News

AI tools can analyze preferences, behaviors, and interests, equipping MSLs (medical science liaisons) with a comprehensive understanding of each individual KOL. AI refines KOL (key opinion leader) outreach by quickly uncovering the intricate details of individual thought leaders.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

TriNet Pharma Highlights the Rise of the Medical Science Liaison and Honors Legacy of Its Founder [Sponsored]

MedCity News

As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.

article thumbnail

Agents of change: How the Gen Z medical science liaison will transform healthcare

MedCity News

Gen Z is the most diverse, digitally-proficient generation yet. Gen Z MSLs have the skills and power to change the future of healthcare by using technology to redefine who KOLs are, how they are engaged, and ultimately, how clinical trials are run – and with it the potential to make health equity a reality.

article thumbnail

We’re at a Turning Point for Alzheimer’s Disease Research

MedCity News

Medical science has made significant strides in the development of advanced treatments over the past decade. However, the majority of FDA-approved treatments for Alzheimer’s focus on the management of symptoms or delayed progression of the disease.

article thumbnail

5 FAQs About Finding & Fostering Relationships with Influential Key Opinion Leaders

MedCity News

It’s critical for medical science liaisons (MSLs) and medical affairs teams to build lasting relationships […].

article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation.